Christopher McCann

654 total citations
20 papers, 395 citations indexed

About

Christopher McCann is a scholar working on Molecular Biology, Surgery and Reproductive Medicine. According to data from OpenAlex, Christopher McCann has authored 20 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Reproductive Medicine. Recurrent topics in Christopher McCann's work include Ovarian cancer diagnosis and treatment (5 papers), Cell death mechanisms and regulation (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Christopher McCann is often cited by papers focused on Ovarian cancer diagnosis and treatment (5 papers), Cell death mechanisms and regulation (4 papers) and Endometrial and Cervical Cancer Treatments (3 papers). Christopher McCann collaborates with scholars based in United Kingdom, United States and Ireland. Christopher McCann's co-authors include John O. Schorge, Marcela G. del Carmen, Whitfield B. Growdon, David M. Boruta, Emma Kerr, Daniel B. Longley, Annekathryn Goodman, Nyree Crawford, Tamas Sessler and Simon S. McDade and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Christopher McCann

20 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher McCann United Kingdom 11 187 136 117 82 80 20 395
Mitsutake Yano Japan 13 174 0.9× 152 1.1× 154 1.3× 52 0.6× 148 1.9× 54 455
Shujie Pang China 8 89 0.5× 114 0.8× 52 0.4× 56 0.7× 64 0.8× 22 282
Ting‐Tai Yen United States 10 172 0.9× 140 1.0× 87 0.7× 52 0.6× 165 2.1× 17 433
Lingfang Xia China 15 118 0.6× 170 1.3× 172 1.5× 93 1.1× 205 2.6× 35 485
Tianzhou Ma United States 8 135 0.7× 147 1.1× 177 1.5× 31 0.4× 113 1.4× 12 499
Peter Widschwendter Germany 12 72 0.4× 54 0.4× 151 1.3× 50 0.6× 86 1.1× 31 306
Eunice H. Rhee United States 5 92 0.5× 146 1.1× 133 1.1× 127 1.5× 105 1.3× 5 403
Gonghua Qi China 10 157 0.8× 91 0.7× 102 0.9× 16 0.2× 105 1.3× 16 365
Daniel L. Spitz United States 7 83 0.4× 157 1.2× 128 1.1× 81 1.0× 64 0.8× 16 300
Kotaro Shimura Japan 10 81 0.4× 58 0.4× 212 1.8× 43 0.5× 59 0.7× 20 365

Countries citing papers authored by Christopher McCann

Since Specialization
Citations

This map shows the geographic impact of Christopher McCann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher McCann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher McCann more than expected).

Fields of papers citing papers by Christopher McCann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher McCann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher McCann. The network helps show where Christopher McCann may publish in the future.

Co-authorship network of co-authors of Christopher McCann

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher McCann. A scholar is included among the top collaborators of Christopher McCann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher McCann. Christopher McCann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McCann, Christopher, et al.. (2022). Rerouting the drug response: Overcoming metabolic adaptation in KRAS-mutant cancers. Science Signaling. 15(756). eabj3490–eabj3490. 6 indexed citations
2.
Crawford, Nyree, Tamas Sessler, Christopher McCann, et al.. (2021). Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal Cancer. Molecular Cancer Therapeutics. 20(9). 1627–1639. 21 indexed citations
3.
McCann, Christopher, Katherine McAllister, Sandra Van Schaeybroeck, et al.. (2021). Development of a protein signature to enable clinical positioning of IAP inhibitors in colorectal cancer. FEBS Journal. 288(18). 5374–5388. 4 indexed citations
4.
McCann, Christopher & Emma Kerr. (2021). Metabolic Reprogramming: A Friend or Foe to Cancer Therapy?. Cancers. 13(13). 3351–3351. 18 indexed citations
5.
Reed, Matthew J., Rachel O’Brien, Polly Black, et al.. (2021). Physiological deterioration in the Emergency Department: The SNAP40-ED study. SHILAP Revista de lepidopterología. 17(3). 1 indexed citations
6.
Mori, Shahram, Deepa Jeyakumar, Michael Keng, et al.. (2021). A phase 4 study to evaluate outpatient blinatumomab in patients with minimal/measurable residual disease (MRD) positivity (+) of B-cell precursor acute lymphoblastic leukemia (BCP-ALL).. Journal of Clinical Oncology. 39(15_suppl). TPS7051–TPS7051. 2 indexed citations
7.
Fichtner, Michael, Emir Bozkurt, Manuela Salvucci, et al.. (2020). Molecular subtype-specific responses of colon cancer cells to the SMAC mimetic Birinapant. Cell Death and Disease. 11(11). 1020–1020. 19 indexed citations
8.
Higgins, Catherine, Joanna Majkut, Tamas Sessler, et al.. (2020). A revised model of TRAIL ‐R2 DISC assembly explains how FLIP (L) can inhibit or promote apoptosis. EMBO Reports. 21(3). e49254–e49254. 40 indexed citations
9.
McCann, Christopher, Katherine Adams, Alexis Schizas, et al.. (2019). Outcomes of emergency laparotomy in patients on extracorporeal membrane oxygenation for severe respiratory failure: A retrospective, observational cohort study. Journal of Critical Care. 53. 253–257. 6 indexed citations
10.
Fichtner, Michael, Katherine McAllister, Christopher McCann, et al.. (2019). Heterogeneous responses to low level death receptor activation are explained by random molecular assembly of the Caspase-8 activation platform. PLoS Computational Biology. 15(9). e1007374–e1007374. 9 indexed citations
11.
McCann, Christopher, Nyree Crawford, Joanna Majkut, et al.. (2018). Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonists. Cell Death and Disease. 9(11). 1081–1081. 12 indexed citations
12.
Reed, Matthew J., Polly Black, Steff Lewis, et al.. (2018). Detection of physiological deterioration by the SNAP40 wearable device compared to standard monitoring devices in the emergency department: the SNAP40-ED study. SHILAP Revista de lepidopterología. 2(1). 18–18. 5 indexed citations
13.
Maxwell, Pamela, Chee Wee Ong, Kelly M. Redmond, et al.. (2016). PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapy. Oncotarget. 7(7). 7885–7898. 32 indexed citations
14.
Garrett, Leslie A. & Christopher McCann. (2013). Abnormal Cytology in 2012. Clinical Obstetrics & Gynecology. 56(1). 25–34. 6 indexed citations
15.
Boruta, David M., Whitfield B. Growdon, Christopher McCann, et al.. (2011). Evolution of surgical management of early-stage endometrial cancer. American Journal of Obstetrics and Gynecology. 205(6). 565.e1–565.e6. 9 indexed citations
16.
McCann, Christopher, Whitfield B. Growdon, Elizabeth Munro, et al.. (2011). Prognostic Significance of Splenectomy as Part of Initial Cytoreductive Surgery in Ovarian Cancer. Annals of Surgical Oncology. 18(10). 2912–2918. 28 indexed citations
17.
McCann, Christopher, Whitfield B. Growdon, Michael D. Curley, et al.. (2011). Inhibition of Hedgehog Signaling Antagonizes Serous Ovarian Cancer Growth in a Primary Xenograft Model. PLoS ONE. 6(11). e28077–e28077. 57 indexed citations
18.
McCann, Christopher, et al.. (2011). Laparoscopic surgical staging of early ovarian cancer.. PubMed. 4(3-4). 117–22. 29 indexed citations
19.
Rauh‐Hain, J. Alejandro, Whitfield B. Growdon, John O. Schorge, et al.. (2010). Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma. Gynecologic Oncology. 119(2). 299–304. 32 indexed citations
20.
Schorge, John O., Christopher McCann, & Marcela G. del Carmen. (2010). Surgical debulking of ovarian cancer: what difference does it make?. PubMed. 3(3). 111–7. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsutake Yano Breakdown of academic impact, for papers by Shujie Pang Breakdown of academic impact, for papers by Ting‐Tai Yen Breakdown of academic impact, for papers by Lingfang Xia Breakdown of academic impact, for papers by Tianzhou Ma Breakdown of academic impact, for papers by Peter Widschwendter Breakdown of academic impact, for papers by Eunice H. Rhee Breakdown of academic impact, for papers by Gonghua Qi Breakdown of academic impact, for papers by Daniel L. Spitz Breakdown of academic impact, for papers by Kotaro Shimura
Rankless by CCL
2026